| 15th Sep 2023 4:30 pm |
RNS |
Director/PDMR Shareholding |
| 5th Sep 2023 7:01 am |
RNS |
New sports medicine product launch |
| 5th Sep 2023 7:00 am |
RNS |
Interim results |
| 31st Aug 2023 1:45 pm |
RNS |
Exercise of Options and Total Voting Rights |
| 21st Aug 2023 7:00 am |
RNS |
Notice of interim results |
| 17th Jul 2023 7:00 am |
RNS |
Half-Year Trading Update |
| 10th Jul 2023 7:00 am |
RNS |
Distribution agreement for OrthoPure® XT in the UK |
| 25th May 2023 7:00 am |
RNS |
Distribution agreement with Australian Allografts |
| 9th May 2023 12:00 pm |
RNS |
Holding(s) in Company |
| 27th Apr 2023 12:35 pm |
RNS |
Result of AGM, Share Reorganisation &TVR |
| 18th Apr 2023 7:00 am |
RNS |
Proposed Share Reorganisation Timetable |
| 5th Apr 2023 2:55 pm |
EQS |
Hardman & Co Research on Tissue Regenix (TRX): Turning profitable and cash-generative |
| 5th Apr 2023 7:00 am |
RNS |
CEO and CFO Share Purchases |
| 30th Mar 2023 7:00 am |
RNS |
Holding(s) in Company |
| 21st Mar 2023 7:00 am |
RNS |
Final results for the year ended 31 December 2022 |
| 6th Mar 2023 7:00 am |
RNS |
Notice of results and Investor presentation |
| 31st Jan 2023 7:01 am |
RNS |
Trading update for 2022 |
| 31st Jan 2023 7:00 am |
RNS |
Change of Adviser |
| 18th Jan 2023 10:06 am |
RNS |
Holding(s) in Company |
| 18th Jan 2023 7:00 am |
RNS |
Chinese distribution agreement for OrthoPure® XT |
| 7th Dec 2022 7:00 am |
RNS |
Product launch in dCELL® division |
| 22nd Nov 2022 7:00 am |
RNS |
Distribution agreement - OrthoPure® XT in Germany |
| 14th Nov 2022 6:05 pm |
RNS |
Holding(s) in Company |
| 7th Nov 2022 2:35 pm |
RNS |
Holding(s) in Company |
| 29th Sep 2022 10:13 am |
RNS |
Director/PDMR Shareholding |
| 27th Sep 2022 7:15 am |
EQS |
Hardman & Co Research on Tissue Regenix (TRX): Operating leverage |
| 7th Sep 2022 7:00 am |
RNS |
Half-year Report |
| 22nd Aug 2022 3:31 pm |
RNS |
Holding(s) in Company |
| 18th Aug 2022 5:36 pm |
RNS |
Holding(s) in Company |
| 18th Aug 2022 2:10 pm |
RNS |
Holding(s) in Company |
| 11th Aug 2022 4:30 pm |
EQS |
Hardman & Co Research: Q&A on Tissue Regenix Group plc: Significantly undervalued which should correct |
| 11th Aug 2022 12:46 pm |
RNS |
Holding(s) in Company |
| 11th Aug 2022 12:17 pm |
RNS |
Holding(s) in Company |
| 11th Aug 2022 7:00 am |
RNS |
Confirmation of Interim Results |
| 5th Aug 2022 3:19 pm |
RNS |
Holding(s) in Company |
| 1st Aug 2022 3:14 pm |
RNS |
Holding(s) in Company |
| 19th Jul 2022 2:30 pm |
EQS |
Hardman & Co Research : Tissue Regenix (TRX): Strong 1H’22 sales suggest upside potential |
| 19th Jul 2022 7:00 am |
RNS |
Half Year Trading Update and Notice of Results |
| 18th Jul 2022 2:42 pm |
RNS |
Holding(s) in Company |
| 18th Jul 2022 1:33 pm |
RNS |
Holding(s) in Company |
